Financial Insights, Inc. Biomarin Pharmaceutical Inc Transaction History

Financial Insights, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	SELL	$87.74 - $117.27 $198,906 - $265,851	-2,267 Reduced 47.0%	2,556 $248,000
Q4 2022 Feb 09, 2023	BUY	$80.93 - $108.63 $168,010 - $225,515	2,076 Added 75.57%	4,823 $499,000
Q3 2022 Oct 26, 2022	BUY	$82.16 - $96.94 $225,693 - $266,294	2,747 New	2,747 $233,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Financial Insights, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Insights, Inc. with notifications on news.